In a blog about enhancing the diagnosis of mental health disorders, Research Assistant Sara Sutori discusses EXPERIENCE, a study of a VR environment designed for the assessment of depressive symptoms, registered at the ISRCTN registry.
Tirzepatide is a new medication offering near-healthy control of blood glucose concentrations and substantial weight loss for patients with type 2 diabetes or obesity. Incretin-based medications make use of the glucose- and weight-lowering properties of the gut hormone glucagon-like peptide-1 (GLP-1) and have revolutionized the treatment of type 2 diabetes. They are equally (and sometimes… Read more »
In a blog about the optimization of patients for surgery, Dr Rebecca Barker discusses SAPIEN, a study of a remote lifestyle coaching program for patients undergoing knee and hip arthroplasty surgery, registered at the ISRCTN registry.